Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies

BACKGROUND AND OBJECTIVE: Acute lymphoblastic leukemia (ALL) is the most common hematologic malignancy of lymphoid origin in children. The prognosis for newly diagnosed ALL in the pediatric population is generally favorable, with a 5-year overall survival rate of more than 90%. Though conventional t...

Descripción completa

Detalles Bibliográficos
Autores principales: Munir, Faryal, He, Jiasen, Connors, Jeremy, Garcia, Miriam, Gibson, Amber, McCall, David, Nunez, Cesar, Dinh, Christine Nguyen, Robusto, Lindsay, Roth, Michael, Khazal, Sajad, Tewari, Priti, Cuglievan, Branko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080491/
https://www.ncbi.nlm.nih.gov/pubmed/37035397
http://dx.doi.org/10.21037/tp-22-656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080491/
https://www.ncbi.nlm.nih.gov/pubmed/37035397
http://dx.doi.org/10.21037/tp-22-656

Ejemplares similares